November Events in Fintech and Biotech
Home > About Us > News & Events > November Events in Fintech and Biotech
November Events in Fintech and Biotech
November 11, 2024
The November conference calendar is already underway for LEAP’s partners and clients in Fintech and Biotech.
We started with the 2024 Annual Meeting of the American Society of Human Genetics - ASHG November 5-9 in Denver, Colorado, where our managing partner Josh Kramer caught up with the most compelling genetics and genomics science of the year, from new technologies, to cutting edge applications, to groundbreaking research.
Also last week, the Institute of Finance and Management (IOFM)’s Fall Conference and Expo took place November 6-8 in Las Vegas, where finance pros gathered to get the latest on ERP systems, digital transformation, and other developments in Fintech.
This week, it’s off to Cambridge, MA for the SLAS (Society for Laboratory Automation and Screening) 2024 Data Sciences and AI Symposium November 12-13 co-hosted by Novartis BioMedical Research. We’re excited for the latest developments in biotech and data science, including image analytics, omics data types, and how innovatory technologies are revolutionizing laboratory automation.
Then it’s the American Fintech Council Policy Summit 2024 November 19 in Washington DC. Talk about being inside the room – industry leaders, regulators, academics, consumer groups and policymakers exchange ideas, explore emerging trends, and shape the future of responsible financial technology.
Next up, head north of the border to Vancouver for the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo November 19-23 in British Columbia, Canada. It’s the foremost gathering of molecular diagnostics professionals to explore cutting-edge advancements in molecular diagnostics and medicine.
We end the month at the forefront of medical innovation with the 6th Annual Congress of Liquid Biopsies November 23-25 in Denver held by International Society of Liquid Biopsy. We’re excited to learn more about liquid biopsy’s potential to transform cancer treatment and patient care.
Are you going to any of these conferences? If so, please tell us in the comments which sessions you plan to attend and what you found most interesting.
And if you’d like to get Leap Consulting Group’s perspectives on the latest developments in fintech and biotech, contact us and let’s talk.